Fig. 3
a Uptake of [111In-DOTA]MG11 in kidneys and AR42J tumors at 4 h pi in SCID mice. Data are given for kidneys and tumors as mean of %ID/g ± SD, n ≥ 4; [111In-DOTA]MG11 iv-coinjection with vehicle (
), with 100 μg Lis (
), with 300 μg PA (
), with a mixture of 100 μg Lis and 300 μg PA (
), with 150 μg TO (
), or 30–40 min after ip injection of 3 mg Race (
); for CCK2R blockade, 40 nmol DG2 [25] was iv-coinjected along with 300 μg PA (
). b Corresponding tumor-to-kidney ratios (Tu/Ki)